Gri Bio Inc. has announced an increase in the number of shares available for issuance under its At The Market Offering Agreement with H.C. Wainwright & Co., LLC. The company has filed a prospectus supplement to raise the maximum number of shares of its common stock, with a par value of $0.0001 per share. The new aggregate total of shares available for issuance is valued at up to $1,758,934. This is in addition to shares already sold under the agreement, which have an aggregate gross sales price of approximately $4,546,137. Legal opinions regarding the issuance and sale of these shares have been provided by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。